Director, Medical Communication & Publications at Genmab

At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

The Role

The Director of Medical Communications & Publications will be responsible for driving the medical communications and publications strategy for assigned solid tumor assets. The individual will play an integral role in driving publication strategy development, planning, and execution of high-quality scientific publications. This role will work closely with other functions and departments, including Clinical Development, Clinical Operations, Market Access, Biostatistics, Commercial, Corporate Communications, and external collaborators to implement the medical communications strategy. Functioning as a member of the Global Medical Affairs department, this individual will report to the Senior Director of Medical Communications and Publications.

This is a hybrid role that requires onsite presence in Princeton, NJ 60% of the time.

Responsibilities
 

• Lead the Medical Communications and Publication initiatives including abstracts, congress presentations, and manuscripts for assigned solid tumor assets and provide expertise to the matrix team in developing and executing the medical communication plan.

• In development of a strategic publication plan, the individual will 1) collaborate with cross-functional, key global stakeholders 2) anticipate risks and identify solutions for publication planning people 3) recognize changes in the healthcare and treatment landscape and adjust publication/communication plans in a timely and efficient manner.

• Serve as a therapy area and product expert for both internal and external stakeholders.

• Develop scientific content deliverables (including but not limited to, scientific communication platform, PLS, FAQs) and congress content obtaining insights from key stakeholders, ensuring development of materials that are aligned with overall asset and therapeutic area strategy.

• Serve as the subject matter expert on publication-related matters establishing strong working closely with both internal and external disease-area experts to ensure high quality analysis, interpretation, communication, and publication planning of data.

• Collaborate effectively with cross functional colleagues and key stakeholders across cultures, backgrounds, and geographies.

• Manage annual budget and work within allocated resources, ensuring contracts, SOWs and invoices are submitted accurately and in a timely manner to ensure high quality deliverables.

• Liaise with agency/vendor partners to ensure timely delivery of quality publication by providing direction, reviewing developed content, and ensuring process is consistent with Genmab SOPs.

• Bring subject matter expertise in discussions regarding the creation or updates to departmental SOPs improving/modifying processes and procedures helping to achieve organizational goals.

Qualifications
 

• Advanced degree: PharmD, PhD or MD required. Certification as a Medical Publication Professional (CMPP) desirable.

• Knowledge of solid tumors/gynecological cancers is preferred.

• 7+ years in medical writing and relevant industry work experience and/or expert in medical communications

• Expertise across all aspects of scientific publication strategy, planning and execution during all phases of drug development and commercialization process.

• Demonstrate an understanding of clinical research principles and disease state knowledge.

• Understanding of clinical trial design and execution, statistical methods and clinical trial data reporting requirements, interpretation and communication.

• Ability to drive and execute within a large matrix, cross-functional team, and work successfully in a fast-paced environment.

• Proven ability to think strategically at an enterprise level and make decisions even under conditions of ambiguity, evolving landscapes, fast paced, and tight timelines.

• In-depth understanding of good publication practices and guidance (GPP, ICMJE), and other guidance related to scientific data communication.

• Ability to travel domestically and international approximately 20% of time.

For US based candidates, the proposed salary band for this position is as follows:

$206,250.00---$343,750.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. 

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website. 

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.